Algicidal activity of Salvia miltiorrhiza Bung on Microcystis aeruginosa—Towards identification of algicidal substance and determination of inhibition mechanism

The present study was to isolate and identify a potent algicidal compound from extract of Salvia miltiorrhiza and study the potential inhibition mechanism on Microcystis aeruginosa. Column chromatography and bioassay-guided fractionation methods were carried out to yield neo-przewaquinone A, which was identified by spectral analysis. The EC50 of neo-przewaquinone A on M. aeruginosa were 4.68 mg L⁻¹. In addition, neo-przewaquinone A showed relatively higher security on Chlorella pyrenoidosa and Scenedesmus obliquus, with the EC50 values of 14.78 and 10.37 mg L⁻¹, respectively. For the potential inhibition mechanisms, neo-przewaquinone A caused M. aeruginosa cells morphologic damage or lysis, increased malondialdehyde content and decreased the soluble protein content, total antioxidant and superoxide dismutase activity, and significantly inhibited three photosynthesis-related genes (psaB, psbD, and rbcL). The results demonstrated the algicidal effect of neo-przewaquinone A on M. aeruginosa and provided the possible inhibition mechanisms.     

In vitro response of human ovarian cancer cells to dietary bioflavonoid isoquercitrin

Abstract

Isoquercitrin is a dietary bioflavonoid used as a food supplement. We studied the mechanism underlying its effect in human ovarian cancer cells using OVCAR-3 cell line. Viability, survival, apoptosis, release of human transforming growth factor-β1 (TGF-β1) and TGF-β1 receptor, and intracellular reactive oxygen species (ROS) generation by OVCAR-3 cells were examined after isoquercitrin treatment at concentrations 5, 10, 25, 50, and 100?μg mL^?1. AlamarBlue assay revealed that isoquercitrin did not cause any significant change (P?>?0.05) in cell viability as compared to control. Apoptotic assay using flow cytometry did not find any significant change (P?>?0.05) in the proportion of live, dead and apoptotic cells as compared to control. ELISA also showed that the release of human TGF-β1 and TGF-β1 receptor were not significantly (P?>?0.05) affected by isoquercitrin as compared to control. Chemiluminescence assay demonstrated that lower concentrations (5, 10, and 25?μg mL^?1) were able to exhibit beneficial effects by inhibiting the generation of intracellular ROS. In contrast, elevated concentrations of 50 and 100?μg mL^?1 led to oxidative stress (P?相似文献   

双室微生物燃料电池处理硝酸盐废水

基于双室微生物燃料电池(microbial fuel cell,MFC),针对阴极分别接种活性污泥(A-MFC)和反硝化细菌(D-MFC),研究其产电情况和硝酸盐废水去除效果。结果表明,在产电的同时都可有效去除废水中的硝酸盐污染物。在外接电阻100Ω的情况下,2种MFC均具有良好的产电性能,A-MFC和D-MFC达到的最大输出电压分别为119.6 mV和117.2mV,最大功率密度分别为23.40 mW/m2和26.63 mW/m2;同时两者在阴极室的平均反硝化速率分别为1.86 mg/(L.d)和2.19 mg/(L.d),阳极室的平均COD去除率分别为81.9%和82.4%。另外,通过扫描电镜观察可知,A-MFC和D-MFC阴极碳布表面形貌存在差异,并且阳极与阴极碳布表面形貌差异显著。     

MFC-MBR耦合系统运行效果

膜生物反应器(MBR)是一种高效的污水处理工艺,而微生物燃料电池(MFC)能有效降解污泥中的胞外生物有机质(EBOM)并回收电能.将MFC与MBR联用,建立了一套能够有效抑制膜污染同时回收电能的新系统——MFC-MBR耦合系统,MBR的剩余污泥经MFC处理后回流.以传统MBR为对照,对耦合系统中污水处理效果、膜污染情况和污泥混合液的性质进行研究.研究表明,耦合系统的污水处理效果没有明显恶化,COD去除率为94％,NH4+-N的去除率为92％.耦合系统能够有效减缓膜污染的发生,清洗周期延长了28％.污泥混合液的MLVSS/MLSS稳定在80％ ～ 88％,系统内几乎没有无机颗粒积累.松散结合态胞外聚合物(LB-EPS)降低了48％,使污泥混合液性质得到改善.较低的污泥比阻(2.69×1012m/kg)和标准化毛细吸水时间(1.67 s·L/g MLSS),证明耦合系统污泥混合液脱水性能提高了.     

Biodegradation and bio-sorption of antibiotics and non-steroidal anti-inflammatory drugs using immobilized cell process

In the present study, the removal mechanisms of four antibiotics (sulfamethoxazole, sulfadimethoxine, sulfamethazine, and trimethoprim) and four non-steroidal anti-inflammatory drugs (acetaminophen, ibuprofen, ketoprofen, and naproxen) in immobilized cell process were investigated using batch reactors. This work principally explores the individual or collective roles of biodegradation and bio-sorption as removal routes of the target pharmaceuticals and the results were validated by various experimental and analytical tools. Biodegradation and bio-sorption were found as dominant mechanisms for the drug removal, while volatilization and hydrolysis were negligible for all target pharmaceuticals. The target pharmaceuticals responded to the two observed removal mechanisms in different ways, typically: (1) strong biodegradability and bio-sorption by acetaminophen, (2) strong biodegradability and weak bio-sorption by sulfamethoxazole, sulfadimethoxine, ibuprofen and naproxen, (3) low biodegradability and weak bio-sorption by sulfamethazine and ketoprofen, and (4) low biodegradability and medium bio-sorption by trimethoprim. In the sorption/desorption experiment, acetaminophen, sulfamethoxazole and sulfadimethoxine were characterized by strong sorption and weak desorption. A phenomenon of moderate sorption and well desorption was observed for sulfamethazine, trimethoprim and naproxen. Both ibuprofen and ketoprofen were weakly sorbed and strongly desorbed.     

Confirmation of polychlorinated biphenyl (PCB) distribution in the blood and verification of simple quantitative method for PCBs based on specific congeners

We measured the concentration of each polychlorinated biphenyl (PCB) congener in whole blood, plasma and blood cells, and investigated the distribution of PCBs in human blood using high-resolution gas chromatography/high-resolution mass spectrometry (HRGC/HRMS). The PCB concentrations in plasma and whole blood in terms of lipid concentrations were almost equal, with a correlation coefficient of r = 0.972. In the blood, the ratio of PCBs in blood cells to those in plasma was generally about 1:9 and the congener distribution patterns in blood cells and plasma were similar.We performed verification of a simple mass screening method by obtaining information on the main PCB congeners for investigations on human accumulation and exposure. The total concentration of the seven PCB congeners (UNEP-7) proposed to the United Nations Environment Programme (UNEP) by Muir and Morita was about 50% of the total concentration of all PCB congeners, and UNEP-30 was about 80%. The seven main congeners in the blood (MCB-7) showed a value that was about 60%, and MCB-30 showed a value that was about 90%. Determinations with the main congeners in the blood showed a correlation of r = 0.990 or more between the main eight congeners (MCB-7 plus #74) and the total PCB concentration for all congeners. The results suggest that, although total PCB concentration can be effectively estimated from the main seven congeners, the main eight congeners would be preferable, and that the use of these congeners in the simple mass screening method would be effective for populations in areas uncontaminated by PCBs.     

Influence of GSTM1 and GSTT1 genotypes and confounding factors on the frequency of sister chromatid exchange and micronucleus among road construction workers

In the present study, we have investigated the influence of polymorphism of GSTM1 and GSTT1 genes and confounding factors such as age, sex, exposure duration and consumption habits on cytogenetic biomarkers. Frequency of sister chromatid exchanges (SCEs), high frequency cell (HFC) and cytokinesis blocked micronuclei (CBMN) were evaluated in peripheral blood lymphocytes of 115 occupationally exposed road construction workers and 105 unexposed individuals. The distribution of null and positive genotypes of glutathione-S transferase gene was evaluated by multiplex PCR among control and exposed subjects. An increased frequency of CBMN (7.03 ± 2.08); SCE (6.95 ± 1.76) and HFC (6.28 ± 1.69) were found in exposed subjects when compared to referent (CBMN - 3.35 ± 1.10; SCE - 4.13 ± 1.30 and HFC - 3.98 ± 1.56). These results were found statistically significant at p < 0.05. When the effect of confounding factors on the frequency of studied biomarkers was evaluated, a strong positive interaction was found. The individuals having GSTM1 and GSTT1 null genotypes had higher frequency of CBMN, SCE and HFC. The association between GSTM1 and GSTT1 genotypes and studied biomarkers was found statistically significant at p < 0.05. Our findings suggest that individuals having null type of GST are more susceptible to cytogenetic damage by occupational exposure regardless of confounding factors. There is a significant effect of polymorphism of these genes on cytogenetic biomarkers which are considered as early effects of genotoxic carcinogens.     

Development of a hybrid microbial fuel cell (MFC) and fuel cell (FC) system for improved cathodic efficiency and sustainability: the M2FC reactor

In an effort to improve the efficiency and sustainability of microbial fuel cell (MFC) technology, a novel MFC reactor, the M2FC, was constructed by combining a ferric-based MFC with a ferrous-based fuel cell (FC). In this M2FC reactor, ferric ion, the catholyte in the MFC component, is regenerated by the FC system with the generation of additional electricity. When the MFC component was operated separately, the electricity generation was maintained for only 98 h due to the depletion of ferric ion in the catholyte. In combination with the fuel cell, however, the production of power was sustained because ferric ion was continually replenished from ferrous ion in the FC component. Moreover, the regeneration process of ferric ion by the FC produced additional energy. The M2FC reactor yielded a power density of up to 2 W m⁻² (or time-averaged value of approximately 650 mW m⁻²), density up to 20 times (or approximately six times based on time-averaged value) higher than the corresponding MFC system.     

MFC强化同步短程硝化反硝化工艺的启动

微生物燃料电池(MFC)可在阴极实现反硝化、短程反硝化和同步硝化反硝化并产生电能,但在MFC阴极实现同步短程硝化反硝化的研究尚未见到报道。为了探讨MFC阴极同步短程硝化反硝化工艺的性能,将双室曝气阴极MFC与A/O脱氮工艺结合处理人工模拟低碳氮比废水。通过静置运行15 d使得MFC阴极室亚硝态氮得以积累,氨氧化菌得以富集。随即改为连续运行后第21天成功启动同步短程硝化反硝化MFC;阴极出水氨氮浓度为0.3 mg/L,亚硝态氮浓度为15.9 mg/L,硝态氮浓度为0.6 mg/L,亚硝化率达到95%以上,阴极电极自养反硝化去除率达到50%以上,COD去除率达到85%以上。结果表明,将MFC与同步短程硝化反硝化工艺结合,通过阴极室中氧气得电子获得高p H,可以强化同步短程硝化反硝化工艺,完成生物脱氮的同时回收电能,并具有减少外加碱度的优势。     

不同诱导条件对结晶产物形貌特征的影响

在流化床反应器中,以含铜废水为处理对象,重点考察了诱导条件改变对结晶系统运行效率及结晶产物形貌特征的影响。结果表明,进水200 mg/L,进药比([Cu2+]/[CO2-3])1∶1.2,p H为10.2的条件下,铜离子去除率可接近100%,诱导晶种表面平滑,诱导颗粒生长成致密杆状晶体结构,以碳酸盐为沉淀剂的诱导结晶系统依赖于体系的p H,高p H体系下发生的共结晶现象是影响系统运行的主要原因;随着进药摩尔比的增加,结晶产物由短杆状向球状转化,晶体机械强度显著降低大量破碎,影响出水水质;进药比1∶1.2,p H为11的条件下,含铜废水浓度为500 mg/L时,系统去除率可达95%以上,微晶产率低于5%。